Axsome Therapeutics (NASDAQ:AXSM) Stock Price Expected to Rise, Bank of America Analyst Says
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report) had its target price boosted by investment analysts at Bank of America ...
HC Wainwright Reiterates “Buy” Rating for Axsome Therapeutics (NASDAQ:AXSM)
Axsome Therapeutics (NASDAQ:AXSM – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC ...
Biotech Alert: Searches spiking for these stocks today
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Pulmonology Advisor22h
FDA Approves Symbravo for Acute Treatment of Migraine in Adults
The US FDA has approved Symbravo (meloxicam and rizatriptan) for the acute treatment of migraine with or without aura in adults.
Zacks Investment Research on MSN20h
Exact Sciences (EXAS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Wall Street expects a year-over-year decline in earnings on higher revenues when Exact Sciences (EXAS) reports results for the quarter ended December 2024. While this widely-known consensus outlook is ...